Usage: Korlym (mifepristone) controls high blood sugar caused by excess cortisol in adults with Cushing's syndrome who also have type 2 diabetes or glucose intolerance, and who have failed surgery or are not surgical candidates.
Usage: Recorlev treats endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or has not been curative. Not approved for fungal infections.